Skip to main content
search
Category

Highlights Archive

HighlightsHighlights Archive

Media Monitoring: 10th – 16th April

First-ever MHRA analysis of UK clinical trial applications finds new opportunities to drive medical breakthroughs for patients The first-ever analysis of the UK clinical trial landscape by the MHRA and the University of Liverpool reveals the UK is a global leader in clinical research – and sets out key opportunities to deliver even more life-changing treatments for patients. It finds…
Ben Kemp
April 15, 2025
HighlightsHighlights Archive

Media Monitoring: 3rd – 9th April

WHO issues its first-ever reports on tests and treatments for fungal infections The WHO published its first-ever reports addressing the critical lack of medicines and diagnostic tools for invasive fungal diseases, showing the urgent need for innovative research and development (R&D) to close these gaps. Fungal diseases are an increasing public health concern, with common infections – such as candida,…
Ben Kemp
April 8, 2025
HighlightsHighlights Archive

Nearly £14bn in R&D funding allocated to DSIT

The Department for Science, Innovation and Technology (DSIT) has set out how it will allocate the record £13.9 billion in funding for transformational research and development in the next year. Areas including life sciences are set to benefit. UK Research and Innovation (UKRI) – the UK’s lead public research funder – will receive £8.8 billion over the next year. However,…
Ben Kemp
April 8, 2025
HighlightsHighlights Archive

Prime Minister announces funding to improve medical research

The Wellcome Institute and the UK Government are launching a major new health data research initiative worth up to £600 million. This new service will streamline secure access to health data, accelerating research aimed at understanding illness and enabling the development of better tools for prevention, diagnosis, and treatment. Funded by £100 million from Wellcome and up to £500 million…
Ben Kemp
April 8, 2025
HighlightsHighlights Archive

Media Monitoring: 28 March – 2 April

MHRA launches initiative to improve communications The Medicines and Healthcare products Regulatory Agency has launched a new monthly safety bulletin, the ‘MHRA Safety Roundup’, as part of its three-year Strategy for Improving Safety Communications. This initiative aims to make information about medicines and medical devices clearer and more accessible for healthcare professionals. The bulletin, sent to subscribers and published online…
Ben Kemp
April 2, 2025
HighlightsHighlights Archive

Government and community pharmacies reach £3bn new deal to provide key services

After a year of negotiations, the government and Community Pharmacy England have reached a £3bn deal to ensure pharmacies can deliver key health services to patients. Ministers hope that increased activity by pharmacies, such as Pharmacy First consultations, will ease pressure on GPs. However, the National Pharmacy Association has challenged the settlement, claiming it falls significantly short of NHS estimates.…
Ben Kemp
March 31, 2025
HighlightsHighlights Archive

Study shows 9% of all MHRA Yellow Card adverse drug reaction reports are gene-related

A new study from Queen Mary University of London found that 9% of all adverse drug reactions (ADRs) reported to the UK medicines regulator are associated with medications where side effect risk is partly dependent on patient’s genes. Of this subset of ADRs, 75% were associated with only three genes that impact how the body processes medication. Genetic testing before…
Ben Kemp
March 31, 2025
Close Menu